Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Toward a pathophysiology of attention-deficit/hyperactivity disorder.

Castellanos FX.

Clin Pediatr (Phila). 1997 Jul;36(7):381-93. Review.

PMID:
9241475
2.

Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.

Staller JA, Faraone SV.

Expert Rev Neurother. 2007 Apr;7(4):351-62. Review.

PMID:
17425490
3.
4.

[Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].

Huber M, Kirchler E, Niederhofer H, Gruber L.

Fortschr Neurol Psychiatr. 2007 May;75(5):275-84. Epub 2006 Nov 17. Review. German.

PMID:
17443438
5.

Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research.

Solanto MV.

Behav Brain Res. 2002 Mar 10;130(1-2):65-71. Review.

PMID:
11864719
6.

Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder.

Sobel LJ, Bansal R, Maia TV, Sanchez J, Mazzone L, Durkin K, Liu J, Hao X, Ivanov I, Miller A, Greenhill LL, Peterson BS.

Am J Psychiatry. 2010 Aug;167(8):977-86. doi: 10.1176/appi.ajp.2010.09091259. Epub 2010 Jul 1.

7.

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW.

Biol Psychiatry. 2011 Jun 15;69(12):e145-57. doi: 10.1016/j.biopsych.2011.02.036. Epub 2011 May 6. Review.

PMID:
21550021
8.

Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.

Frank MJ, Santamaria A, O'Reilly RC, Willcutt E.

Neuropsychopharmacology. 2007 Jul;32(7):1583-99. Epub 2006 Dec 13.

9.

Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.

Rastmanesh R.

Atten Defic Hyperact Disord. 2010 Nov;2(3):149-57. doi: 10.1007/s12402-010-0033-z. Epub 2010 Sep 14. Review.

PMID:
21432601
10.

MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.

Schweren LJ, de Zeeuw P, Durston S.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1151-64. doi: 10.1016/j.euroneuro.2012.10.014. Epub 2012 Nov 17. Review.

PMID:
23165220
11.

[Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].

Emond V, Joyal C, Poissant H.

Encephale. 2009 Apr;35(2):107-14. doi: 10.1016/j.encep.2008.01.005. Epub 2008 Jul 7. Review. French.

PMID:
19393378
12.

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD.

Neuropsychol Rev. 2007 Mar;17(1):39-59. Review.

PMID:
17318414
13.

Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment.

Pliszka SR, Glahn DC, Semrud-Clikeman M, Franklin C, Perez R 3rd, Xiong J, Liotti M.

Am J Psychiatry. 2006 Jun;163(6):1052-60.

PMID:
16741206
14.

Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Arnsten AF.

J Clin Psychiatry. 2006;67 Suppl 8:7-12. Review.

15.

Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.

Denney CB.

J Clin Child Psychol. 2001 Mar;30(1):98-109. Review.

PMID:
11294083
16.

The neurobiological basis of ADHD.

Curatolo P, D'Agati E, Moavero R.

Ital J Pediatr. 2010 Dec 22;36(1):79. doi: 10.1186/1824-7288-36-79. Review.

17.

Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.

Stahl SM.

J Clin Psychiatry. 2010 Jan;71(1):12-3. doi: 10.4088/JCP.09bs05890pur. Review. No abstract available.

18.

A two-part model of stimulant action on attention-deficit hyperactivity disorder in children.

McCracken JT.

J Neuropsychiatry Clin Neurosci. 1991 Spring;3(2):201-9. Review. No abstract available.

PMID:
1687963
19.

The dopamine theory of attention deficit hyperactivity disorder (ADHD).

Levy F.

Aust N Z J Psychiatry. 1991 Jun;25(2):277-83. Review.

PMID:
1652243
20.

Pathophysiology of NSS in ADHD.

Pasini A, D'agati E.

World J Biol Psychiatry. 2009;10(4 Pt 2):495-502. doi: 10.1080/15622970902789148. Review.

PMID:
19337883

Supplemental Content

Support Center